Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or
Genprex Inc (GNPX)
Genprex Inc (GNPX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Genprex Inc 3300 Bee Cave Road #650-227 AUSTIN TX 78746 USA

www.genprex.com P: 512-537-7997

Description:

Genprex Inc. operates as a biotechnology company. It discovers and develops immunogene therapies for cancer treatment as well as clinical research, gene therapies, consulting and other related medical services. The company's initial product candidate is Oncoprex(TM) immunogene therapy which treats non-small cell lung cancer. Genprex Inc. is based in United States.

Key Statistics

Overview:

Market Capitalization, $K 6,479
Enterprise Value, $K -14,471
Shares Outstanding, K 1,486
Annual Sales, $ 0 K
Annual Net Income, $ -23,740 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -7,750 K
EBIT, $ -31,900 K
EBITDA, $ -31,870 K
60-Month Beta -0.47
% of Insider Shareholders 11.54%
% of Institutional Shareholders 14.05%
Float, K 1,314
% Float 88.46%
Short Volume Ratio 0.42

Growth:

1-Year Return -91.89%
3-Year Return -97.75%
5-Year Return -92.50%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -5.20 on 11/14/23
Latest Earnings Date 03/29/24
Earnings Per Share ttm -24.80
EPS Growth vs. Prev Qtr 13.33%
EPS Growth vs. Prev Year 0.00%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%
Most Recent Split 1-40 on 02/02/24

GNPX Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -194.71%
Return-on-Assets % -156.61%
Profit Margin % 0.00%
Debt/Equity 0.00
Price/Sales N/A
Price/Cash Flow N/A
Price/Book 0.53
Book Value/Share 8.26
Interest Coverage -0.93
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar